Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0403608 (
ureter
)
9,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We present a case of primary ureteral carcinoma in the duplicated renal pelvis and
ureter
diagnosed by transurethral uretero-renoscopy. The case was of a 78-year-old man with the complaint of sudden asymptomatic macrohematuria. An excretory urogram strongly suggested the presence of duplication of the right collecting system, and cystoscopy revealed a gross hematuria from the right ureteral orifice. A retrograde ureteropyelogram revealed incomplete duplication of the right renal pelvis and
ureter
fused at about the
ureter
crossing over the iliac vessels, and a polyp-like filling defect in the lower segment of duplicated
ureter
at about 4 cm from the fusion of the ureters. Transurethral uretero-renoscopy was employed to investigate the filling defect, and a papillary tumor extended into the lower segment of duplicated
ureter
was revealed. Tumor was resected by a rigid operating instrument under transurethral uretero-renoscopy. The pathological diagnosis was grade I-
transitional cell carcinoma
of the
ureter
, so that right total nephroureterectomy with partial cystectomy was carried out subsequently. Surgical specimen after right total nephroureterectomy with partial cystectomy showed no other tumor in the pelvis or
ureter
macroscopically, and histopathological studies of surgical specimens were no evidence of malignancy. We believe that transurethral uretero-renoscopy significantly increases the diagnostic accuracy in determining the nature of upper urinary tract lesions, and this procedure is indispensable in the diagnosis of ureteral tumors. The present case was the 7th case of primary ureteral carcinoma in the duplicated renal pelvis and
ureter
in the Japanese literature.
...
PMID:[A case of primary ureteral carcinoma in the duplicated renal pelvis and ureter diagnosed by transurethral uretero-renoscopy]. 372 47
In a patient with
transitional cell carcinoma
of the pelvis of a solitary kidney there were extensive recurrences in the
ureter
and bladder. The treatment consisted of total cystoureterectomy and pyeloileocutaneostomy for urinary diversion and endoscopic control of the pelvic neoplastic growth.
...
PMID:Pyelocutaneous ileal conduit for endoscopic control of recurrent renal pelvic tumour. A case report. 374 21
A retrospective study was conducted on 22 patients with renal pelvic tumor treated at our University Hospital between 1970 and 1984. The patients included 18 males and 4 females, from 31 to 81 years of age. The left kidney was involved in 14 cases, and the right in 8. More than 60% of them also presented gross hematuria. IVP abnormalities included filling defects in 9 cases and non-visualizing kidney in 8 cases. Pretreatment urinary cytology was positive in 65.7%. Radical nephroureterectomy was performed in 18 cases, followed by adjuvant therapy in 10 cases; radiation in 5 cases, chemotherapy in 4 cases, and radiation/chemotherapy in one case. Histology revealed
transitional cell carcinoma
in all cases. On diagnosis, simultaneous urothelial tumors were identified in one case in the
ureter
and the bladder, and in one case in the bladder. Tumor development after surgery was observed in 9 cases, 8 in the bladder and one in the ipsilateral renal pelvis. The 5-year actual survival rate was 58.2% over all: that of the low-grade group was 100%; that of the high-grade group, 45.1%; that of the low-stage group, 100%; that of the high-stage group, 19%. In conclusion, the prognosis in our series was significantly influenced by the stage and grade of the tumor.
...
PMID:[Clinical study of renal pelvic tumors]. 375 65
The standard surgical management of patients presenting with
transitional cell carcinoma
of the upper urinary tract is nephroureterectomy with excision of a cuff of bladder around the ureteric orifice. Recently a modified technique of resecting the lower
ureter
endoscopically and completing the nephroureterectomy through a single loin incision has been advocated as a safe and simple procedure. We consider that this technique may have a risk of tumour implantation at the site of the resected lower
ureter
. We report our experience of this operation in five patients, two of whom developed invasive tumour at the site of the ureteric orifice after only a short follow-up.
...
PMID:Modified nephroureterectomy: a risk of tumour implantation. 375 2
A case of ureteral intussusception caused by a low-grade papillary
transitional cell carcinoma
of the
ureter
is described. This is the first case of ureteral intussusception resulting from a malignant tumor of the
ureter
. The patient presented with weight loss and vague pain in the right lower abdominal quadrant. Right ureterovesical junction obstruction was seen in the retrograde pyeloureterogram. Right nephroureterectomy including a cuff of adjacent bladder wall was performed.
...
PMID:Ureteral intussusception by papillary transitional cell carcinoma. 376 42
Chronic irritation or infection may cause a neoplastic change in the uroepithelium. Our recent experience with two cases of
transitional cell carcinoma
associated with such stimuli is reported. A 58-year-old woman was found to have a staghorn stone in the left kidney and underwent nephrectomy because of an atrophic kidney.
Transitional cell carcinoma
was incidentally identified microscopically on the renal pelvis of the removed kidney. Subsequently surgery was elected to remove the residual
ureter
and the retroperitoneal lymph nodes, both of which turned out to be non-malignant. Then, she was treated by combination chemotherapy with CTX, ADR and CDDP. The second case was a 77-year-old woman who had had a 15-year history of an indwelling
ureter
catheter after gynecological surgery. Because of purulent discharge without any urine production, she underwent nephrectomy for a contracted kidney. Histology revealed
transitional cell carcinoma
on the pelviureteral junction. The postoperative courses were uneventful in both cases: they were followed up for 6 months and 9 months respectively without any recurrence of the disease. 90 cases of renal pelvic tumors associated with renal stones were collected from the Japanese literature and reviewed.
...
PMID:[Transitional cell carcinoma developed in association with renal stone and ureter catheter: report of two cases]. 376 45
A case of synchronous contralateral renal cell carcinoma and ureteral
transitional cell carcinoma
is reported. A 56-year-old man, who had been incidentally found to have an abnormal mass in the upper pole of the right kidney on ultrasound sonography, was admitted on January 8, 1985. CT scanning and renal arteriography revealed right renal malignancy. Right radical nephrectomy was performed and histological examination showed adenocarcinoma, granular cell type of the right kidney. He was discharged on February 3, 1985. Two months postoperatively, he was rehospitalized for macroscopic hematuria. Left retrograde pyelogram showed obstruction at middle
ureter
and cytology of urine from left
ureter
was positive. So a left ureteral tumor was suspected, and partial resection of left
ureter
and ureteroureterostomy were performed. Histological examination revealed ureteral
transitional cell carcinoma
. He is now doing well at 6 months following the lat surgery, without any evidence of recurrence.
...
PMID:[A case of synchronous contralateral renal cell carcinoma and ureteral transitional cell carcinoma]. 377 65
Patients with carcinoma of the urinary bladder have a poor prognosis. When distant metastasis develops, such patients seldom survive for more than several months. For them, surgery and/or radiotherapy are of little value, and systemic chemotherapy has been thought to be the most useful treatment. Forty-six patients with advanced
transitional cell carcinoma
, including bladder cancer, (33 bladder, 9
ureter
, 4 renal pelvis cases) were treated by a three drug combination chemotherapy, using two protocols (protocol I: adriamycin + cyclophosphamide + 5-fluorouracil, protocol II: adriamycin + cyclophosphamide + cis-platinum). Protocol I induced responses in 5 of the 24 patients (21%, 1 complete response, 4 partial responses), and protocol II in 7 of the 22 patients (32%, 1 complete response, 6 partial responses). The overall response rate was 26%. The durations of response (median duration 5.1 months) and of survival (median duration 11.3 months) in all responders were relatively short. The three-combination chemotherapy, especially protocol II, was effective against
transitional cell carcinoma
of the urinary tract, but the results were not satisfactory.
...
PMID:[Combination chemotherapy of advanced bladder cancer]. 382 29
Five cases (3M, 2F) of ureteral
transitional cell carcinoma
are reported. they have been observed in the last two years in a general surgical service. All the patients have been treated surgically. Gross hematuria was present in all the patients. Three cases had multicentric tumor sites. Three tumors were located in the distal
ureter
. Four cases showed a non functioning kidney at IVP. In two, because of obstruction, retrograde pyelography was unsuccessful. Ultrasound was able to demonstrate hydronephrosis. In the two cases submitted to angio-CT the spread of the tumor was correctly diagnosed. Frequency, etiology, clinical, diagnostic findings and surgical therapy as well have all been taken into account, based on the literature. Histopathologic aspects, grade and stage, are considered too. The authors emphasize the necessity to find and understand the cause of an unexplained hematuria, since ureteral carcinoma is not as rare as previously thought. Being grade and stage closely related to prognosis, the diagnostic delay must be reduced.
...
PMID:Primary ureteral carcinoma. Experience in a general surgical service. 390 1
Primary
transitional cell carcinoma
of the
ureter
is a relatively rare cancer. A case of
transitional cell carcinoma
of the mid-portion of the
ureter
in an adult male has been studied cytogenetically and has been found to have trisomy of chromosome #7 (+7) as the only karyotypic abnormality. In an earlier instance of
transitional cell carcinoma
of the
ureter
, we observed trisomy 7 together with monosomy 9 and an isochromosome for 5p. The relation of this observation to the cytogenetic findings in transitional cell carcinoma of the bladder is discussed and their possible significance evaluated. The rarity of the cytogenetic findings in these tumors is stressed, as is the possible role played by the chromosomal change in this condition, which may possibly involve the c-erb B oncogene.
...
PMID:Chromosome change in transitional cell carcinoma of ureter. 394 51
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>